Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors

Mark A. Watson, Arie Perry, Tarik Tihan, Richard A. Prayson, Abhijit Guha, Julia Bridge, Rosalie Ferner, David H. Gutmann

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) and respond poorly to current therapeutic regimens. To better understand the molecular heterogeneity of these tumors, we performed gene expression profiling on 25 NF1-associated and 17 sporadic MPNSTs using oligonucleotide microarrays representing approximately 8100 unique human gene transcripts. Using several previously reported statistical approaches, we were unable to identify a molecular signature that could reliably distinguish between NF1-associated and sporadic MPNSTs in independent training and test sample sets. However, using an unsupervised clustering approach, we identified an extensive gene expression signature that distinguished 9 of the 42 tumors analyzed. This signature corresponded to relative overexpression of transcripts associated with neuroglial differentiation (NCAM, MBP, L1CAM, P1P) and relative down-regulation of proliferation and growth factor associated transcripts (IGF2, FGFR1, MDK, Ki67). All tumors with this gene expression signature lacked expression of EGFR and all but one tumor were derived from patients with NF1. However, there were no other obvious associations with histological grade, tumor site, metastasis, recurrence, age, or patient survival. We conclude that distinct molecular classes of MPNST exist and that the ability to stratify these tumors based on unique and biologically relevant gene expression profiles may be important for future targeted therapeutics.

Original languageEnglish (US)
Pages (from-to)297-303
Number of pages7
JournalBrain Pathology
Volume14
Issue number3
StatePublished - Jul 1 2004

Fingerprint

Neurofibromatosis 1
Neurilemmoma
Gene Expression Profiling
Transcriptome
Neoplasms
Neural Cell Adhesion Molecule L1
Neural Cell Adhesion Molecules
Schwann Cells
Oligonucleotide Array Sequence Analysis
Cluster Analysis
Intercellular Signaling Peptides and Proteins
Down-Regulation
Neoplasm Metastasis
Recurrence
Survival
Therapeutics
Genes

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Watson, M. A., Perry, A., Tihan, T., Prayson, R. A., Guha, A., Bridge, J., ... Gutmann, D. H. (2004). Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathology, 14(3), 297-303.

Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors. / Watson, Mark A.; Perry, Arie; Tihan, Tarik; Prayson, Richard A.; Guha, Abhijit; Bridge, Julia; Ferner, Rosalie; Gutmann, David H.

In: Brain Pathology, Vol. 14, No. 3, 01.07.2004, p. 297-303.

Research output: Contribution to journalArticle

Watson, MA, Perry, A, Tihan, T, Prayson, RA, Guha, A, Bridge, J, Ferner, R & Gutmann, DH 2004, 'Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors', Brain Pathology, vol. 14, no. 3, pp. 297-303.
Watson, Mark A. ; Perry, Arie ; Tihan, Tarik ; Prayson, Richard A. ; Guha, Abhijit ; Bridge, Julia ; Ferner, Rosalie ; Gutmann, David H. / Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors. In: Brain Pathology. 2004 ; Vol. 14, No. 3. pp. 297-303.
@article{1f44c82a0ee542bcbbc49b99a3d28a73,
title = "Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors",
abstract = "Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) and respond poorly to current therapeutic regimens. To better understand the molecular heterogeneity of these tumors, we performed gene expression profiling on 25 NF1-associated and 17 sporadic MPNSTs using oligonucleotide microarrays representing approximately 8100 unique human gene transcripts. Using several previously reported statistical approaches, we were unable to identify a molecular signature that could reliably distinguish between NF1-associated and sporadic MPNSTs in independent training and test sample sets. However, using an unsupervised clustering approach, we identified an extensive gene expression signature that distinguished 9 of the 42 tumors analyzed. This signature corresponded to relative overexpression of transcripts associated with neuroglial differentiation (NCAM, MBP, L1CAM, P1P) and relative down-regulation of proliferation and growth factor associated transcripts (IGF2, FGFR1, MDK, Ki67). All tumors with this gene expression signature lacked expression of EGFR and all but one tumor were derived from patients with NF1. However, there were no other obvious associations with histological grade, tumor site, metastasis, recurrence, age, or patient survival. We conclude that distinct molecular classes of MPNST exist and that the ability to stratify these tumors based on unique and biologically relevant gene expression profiles may be important for future targeted therapeutics.",
author = "Watson, {Mark A.} and Arie Perry and Tarik Tihan and Prayson, {Richard A.} and Abhijit Guha and Julia Bridge and Rosalie Ferner and Gutmann, {David H.}",
year = "2004",
month = "7",
day = "1",
language = "English (US)",
volume = "14",
pages = "297--303",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Gene expression profiling reveals unique molecular subtypes of neurofibromatosis type I-associated and sporadic malignant peripheral nerve sheath tumors

AU - Watson, Mark A.

AU - Perry, Arie

AU - Tihan, Tarik

AU - Prayson, Richard A.

AU - Guha, Abhijit

AU - Bridge, Julia

AU - Ferner, Rosalie

AU - Gutmann, David H.

PY - 2004/7/1

Y1 - 2004/7/1

N2 - Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) and respond poorly to current therapeutic regimens. To better understand the molecular heterogeneity of these tumors, we performed gene expression profiling on 25 NF1-associated and 17 sporadic MPNSTs using oligonucleotide microarrays representing approximately 8100 unique human gene transcripts. Using several previously reported statistical approaches, we were unable to identify a molecular signature that could reliably distinguish between NF1-associated and sporadic MPNSTs in independent training and test sample sets. However, using an unsupervised clustering approach, we identified an extensive gene expression signature that distinguished 9 of the 42 tumors analyzed. This signature corresponded to relative overexpression of transcripts associated with neuroglial differentiation (NCAM, MBP, L1CAM, P1P) and relative down-regulation of proliferation and growth factor associated transcripts (IGF2, FGFR1, MDK, Ki67). All tumors with this gene expression signature lacked expression of EGFR and all but one tumor were derived from patients with NF1. However, there were no other obvious associations with histological grade, tumor site, metastasis, recurrence, age, or patient survival. We conclude that distinct molecular classes of MPNST exist and that the ability to stratify these tumors based on unique and biologically relevant gene expression profiles may be important for future targeted therapeutics.

AB - Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) and respond poorly to current therapeutic regimens. To better understand the molecular heterogeneity of these tumors, we performed gene expression profiling on 25 NF1-associated and 17 sporadic MPNSTs using oligonucleotide microarrays representing approximately 8100 unique human gene transcripts. Using several previously reported statistical approaches, we were unable to identify a molecular signature that could reliably distinguish between NF1-associated and sporadic MPNSTs in independent training and test sample sets. However, using an unsupervised clustering approach, we identified an extensive gene expression signature that distinguished 9 of the 42 tumors analyzed. This signature corresponded to relative overexpression of transcripts associated with neuroglial differentiation (NCAM, MBP, L1CAM, P1P) and relative down-regulation of proliferation and growth factor associated transcripts (IGF2, FGFR1, MDK, Ki67). All tumors with this gene expression signature lacked expression of EGFR and all but one tumor were derived from patients with NF1. However, there were no other obvious associations with histological grade, tumor site, metastasis, recurrence, age, or patient survival. We conclude that distinct molecular classes of MPNST exist and that the ability to stratify these tumors based on unique and biologically relevant gene expression profiles may be important for future targeted therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=4143097906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4143097906&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 297

EP - 303

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 3

ER -